世界の抗生物質市場は2023年に約452億1,000万米ドルと評価され、2024年から2032年にかけて3.7%の安定した年間複合成長率（CAGR）で成長し、予測期間の終わりまでに市場規模が649億米ドルに達すると予想されています。
抗生物質は細菌感染症と戦う上で極めて重要であり、細菌を殺すかその増殖を阻害することによって作用するため、肺炎、尿路感染症、敗血症などのさまざまな感染症の治療に重要な役割を果たします。これらの薬は、手術後の感染を防ぐために手術で予防的にも使用されます。しかし、抗生物質の過剰使用や誤用は抗生物質耐性菌の出現につながる可能性があり、市場に大きな課題をもたらします。
感染症の蔓延の増加は、世界の抗生物質市場の主な原動力の 1 つです。肺炎、結核、敗血症などの細菌感染症が、特に高度な医療へのアクセスが限られている地域で広く発生しているため、効果的な抗生物質治療に対する大きな需要が引き続き生まれています。この需要は、特に医療インフラが着実に改善している発展途上地域で、医療サービスに対する意識とアクセス性が高まることでさらに高まります。医療へのアクセスを向上させ、感染症と闘うことを目的とした政府の取り組みも、市場の成長軌道に貢献しています。さらに、薬剤耐性菌を標的とした新しい抗生物質の研究開発（R&D）が進行中であり、市場にとって大きな成長の機会となっています。メチシリン耐性黄色ブドウ球菌（MRSA）などの抗生物質耐性菌の出現により、新しい効果的な抗生物質の必要性が高まっています。製薬会社は、これらの課題に対処するために革新的な薬剤処方や次世代の抗生物質への投資を増やしており、市場拡大を促進しています。しかし、抗生物質耐性の増加は、世界の抗生物質医薬品市場にとって大きな課題となっています。抗生物質の誤用や過剰使用は、耐性菌株の発生を招き、既存の医薬品の有効性を低下させます。このため、新しい抗生物質を継続的に開発する必要があり、そのプロセスにはコストと時間がかかります。さらに、規制上のハードルや研究開発に必要な多額の投資が市場環境をさらに複雑にし、成長を阻害する可能性があります。
地域的には、予測期間中に北アメリカが世界の抗生物質市場を支配すると予想されています。この優位性は、抗菌薬の規制承認数の増加に起因し、市場の成長を促進すると予想されます。この地域の確立された医療インフラと主要な市場プレーヤーの強力な存在は、その主導的地位をさらに強化します。一方、アジア太平洋、ラテンアメリカ、アフリカの新興市場では、医療へのアクセスとインフラの改善、可処分所得の増加、医療オプションの認識の高まりにより、大幅な成長の機会が提供されると予想されています。一方、アジア太平洋の市場は、予測期間2024年から2032年に最も速い速度で成長すると予想されています。
目次
Table of Contents
Chapter 1. Global Antibiotic Drugs Market Executive Summary
1.1. Global Antibiotic Drugs Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Drug Class
1.3.2. By Indication
1.3.3. By Route of Administration
1.3.4. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Antibiotic Drugs Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Antibiotic Drugs Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Infectious Diseases
3.1.2. Growing Awareness and Access to Healthcare
3.1.3. R&D in Novel Antibiotics
3.2. Market Challenges
3.2.1. Antibiotic Resistance
3.2.2. High Cost of New Drug Development
3.3. Market Opportunities
3.3.1. Rising Geriatric Population
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Antibiotic Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Antibiotic Drugs Market Size & Forecasts by Drug Class 2022-2032
5.1. Segment Dashboard
5.2. Global Antibiotic Drugs Market: Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Penicillins
5.2.2. Fluoroquinolones
5.2.3. Cephalosporins
5.2.4. Macrolides
5.2.5. Others
Chapter 6. Global Antibiotic Drugs Market Size & Forecasts by Indication 2022-2032
6.1. Segment Dashboard
6.2. Global Antibiotic Drugs Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Dermatological Infections
6.2.2. Respiratory Infections
6.2.3. Urinary Tract Infections
6.2.4. Ear Infections
6.2.5. Gastrointestinal Infections
6.2.6. Others
Chapter 7. Global Antibiotic Drugs Market Size & Forecasts by Route of Administration 2022-2032
7.1. Segment Dashboard
7.2. Global Antibiotic Drugs Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Oral
7.2.2. Parenteral
Chapter 8. Global Antibiotic Drugs Market Size & Forecasts by Distribution Channel 2022-2032
8.1. Segment Dashboard
8.2. Global Antibiotic Drugs Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Retail Pharmacies
8.2.2. Hospital Pharmacies
8.2.3. Online Pharmacies
Chapter 9. Global Antibiotic Drugs Market Size & Forecasts by Region 2022-2032
9.1. North America Antibiotic Drugs Market
9.1.1. U.S. Antibiotic Drugs Market
9.1.1.1. Drug Class breakdown size & forecasts, 2022-2032
9.1.1.2. Indication breakdown size & forecasts, 2022-2032
9.1.1.3. Route of Administration breakdown size & forecasts, 2022-2032
9.1.1.4. Distribution Channel breakdown size & forecasts, 2022-2032
9.1.2. Canada Antibiotic Drugs Market
9.2. Europe Antibiotic Drugs Market
9.2.1. U.K. Antibiotic Drugs Market
9.2.2. Germany Antibiotic Drugs Market
9.2.3. France Antibiotic Drugs Market
9.2.4. Spain Antibiotic Drugs Market
9.2.5. Italy Antibiotic Drugs Market
9.2.6. Rest of Europe Antibiotic Drugs Market
9.3. Asia-Pacific Antibiotic Drugs Market
9.3.1. China Antibiotic Drugs Market
9.3.2. India Antibiotic Drugs Market
9.3.3. Japan Antibiotic Drugs Market
9.3.4. Australia Antibiotic Drugs Market
9.3.5. South Korea Antibiotic Drugs Market
9.3.6. Rest of Asia Pacific Antibiotic Drugs Market
9.4. Latin America Antibiotic Drugs Market
9.4.1. Brazil Antibiotic Drugs Market
9.4.2. Mexico Antibiotic Drugs Market
9.4.3. Rest of Latin America Antibiotic Drugs Market
9.5. Middle East & Africa Antibiotic Drugs Market
9.5.1. Saudi Arabia Antibiotic Drugs Market
9.5.2. South Africa Antibiotic Drugs Market
9.5.3. Rest of Middle East & Africa Antibiotic Drugs Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Abbott Laboratories
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. AbbVie
10.3.3. F. Hoffmann-La Roche Ltd.
10.3.4. GlaxoSmithKline plc
10.3.5. Merck & Co. Inc.
10.3.6. Mylan N.V.
10.3.7. Novartis International AG (Sandoz)
10.3.8. Sanofi
10.3.9. Teva Pharmaceutical Industries Ltd.
10.3.10. Melinta Therapeutics
10.3.11. Pfizer Inc.
10.3.12. Basilea Pharmaceutica Ltd.
10.3.13. Tetraphase Pharmaceuticals
10.3.14. Paratek Pharmaceuticals, Inc.
10.3.15. Nabriva Therapeutics plc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
List of Tables
TABLE 1. Global Antibiotic Drugs Market, report scope
TABLE 2. Global Antibiotic Drugs Market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Antibiotic Drugs Market estimates & forecasts by Drug Class 2022-2032 (USD Billion)
TABLE 4. Global Antibiotic Drugs Market estimates & forecasts by Indication 2022-2032 (USD Billion)
TABLE 5. Global Antibiotic Drugs Market estimates & forecasts by Route of Administration 2022-2032 (USD Billion)
TABLE 6. Global Antibiotic Drugs Market estimates & forecasts by Distribution Channel 2022-2032 (USD Billion)
TABLE 7. Global Antibiotic Drugs Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Antibiotic Drugs Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Antibiotic Drugs Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Antibiotic Drugs Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. U.S. Antibiotic Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. U.S. Antibiotic Drugs Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 13. Canada Antibiotic Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Canada Antibiotic Drugs Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 15. U.K. Antibiotic Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. Germany Antibiotic Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 17. France Antibiotic Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 18. Spain Antibiotic Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Italy Antibiotic Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 20. China Antibiotic Drugs Market estimates & forecasts, 2022-2032 (USD Billion)
…..
This list is not complete, the final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Antibiotic Drugs Market, research methodology
FIG 2. Global Antibiotic Drugs Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Antibiotic Drugs Market, key trends 2023
FIG 5. Global Antibiotic Drugs Market, growth prospects 2022-2032
FIG 6. Global Antibiotic Drugs Market, Porter’s 5 force model
FIG 7. Global Antibiotic Drugs Market, PESTEL analysis
FIG 8. Global Antibiotic Drugs Market, value chain analysis
FIG 9. Global Antibiotic Drugs Market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Antibiotic Drugs Market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Antibiotic Drugs Market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Antibiotic Drugs Market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Antibiotic Drugs Market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Antibiotic Drugs Market, regional snapshot 2022 & 2032
FIG 15. North America Antibiotic Drugs Market 2022 & 2032 (USD Billion)
FIG 16. Europe Antibiotic Drugs Market 2022 & 2032 (USD Billion)
FIG 17. Asia Pacific Antibiotic Drugs Market 2022 & 2032 (USD Billion)
FIG 18. Latin America Antibiotic Drugs Market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Antibiotic Drugs Market 2022 & 2032 (USD Billion)
FIG 20. Global Antibiotic Drugs Market, company market share analysis (2023)
…..
This list is not complete, the final report does contain more than 50 figures. The list may be updated in the final deliverable.
